Navigation Links
Inaugural Obliteride Sets Northwest Fundraising Record
Date:10/23/2013

SEATTLE, Oct. 23, 2013 /PRNewswire/ -- The inaugural Obliteride was a huge success. In its first year, Obliteride raised more money for a local organization than any other bicycling fundraiser in the Northwest. The inaugural ride raised $1.9 million that will go directly to lifesaving research at Fred Hutchinson Cancer Research Center in Seattle.

(Photo: http://photos.prnewswire.com/prnh/20131023/AQ03396)  

"We are so impressed with how our community rallied around Obliteride and its commitment to raising money to accelerate lifesaving research at Fred Hutch," said Amy Lavin, Obliteride's executive director. "We set out to do something big our first year and people wowed us by donating $1.9 million to Fred Hutch."

More than 1,600 people participated in the August event, including riders, volunteers and virtual riders. "It was a magical weekend that we hope even more people will get to experience next year," Lavin said.

Putting the Money to Work to End Cancer
Obliteride's generous sponsors, including anchor sponsors University Village and The Sloan Foundation, ensure that 100 percent of every dollar raised stays right here in our community and goes directly to lifesaving research at Fred Hutch. This breakthrough research creates hope for the thousands of people diagnosed with cancer every year and helps save lives around the world.

Obliteride's funds will be put to use in the areas of highest need to fund the most promising research at Fred Hutch. Some of the funds will be used for accelerating research in immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects and less toxicity. Funds will also support prostate cancer and pediatric brain cancer research.

"Obliteride is a way for our entire community to be part of the Hutch's mission to end cancer," said Dr. Fred Appelbaum, executive vice president and deputy director of Fred Hutch."Contributions from individuals, corporations and private foundations are more critical now than ever because of federal cutbacks. We have so many exciting and game-changing projects going on right now. Funding is essential; lives are counting on it."

A Weekend to Remember
"The financial impact we're having on cancer research is rewarding, and it's matched by the smiles on faces at Obliteride," Lavin continued. "The weekend truly was an event to remember. People came ready to ride and spend time with friends. They left inspired and rejuvenated. The sense of accomplishment, top-notch service, delicious fare, and entertainment left people energized. Together we made a positive impact on cancer research."

Save the date: Obliteride 2014 weekend is Aug. 8-10. Details will be announced in early January when registration opens. For more information, visit www.obliteride.org.

Contact:
Amy Anderson
Obliteride Media Relations
Fred Hutchinson Cancer Research Center
amya@obliteride.org
206-310-1965


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Inaugural Denton A. Cooley Fellow of Surgical Innovation named at Texas Childrens Hospital
2. MicroVentions New Manufacturing Plant Facility In Costa Rica Celebrates Grand Opening With Inaugural Plant Ceremony
3. AbbVie Issues Inaugural Full-Year Outlook for 2013
4. Academy of Managed Care Pharmacy Collaborates with National Association of Specialty Pharmacy to Host Inaugural AMCP/NASP Specialty Pharmacy Conference
5. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
6. Abaxis, Inc. to Participate in Sidoti & Companys Inaugural One-on-One Conference
7. Specialty Pharmacy Certification Board Announces Inaugural Board of Directors
8. Edwards Lifesciences Chief Medical Officer to Keynote the Inaugural MedTech Cardio 2012 Conference at the MD&M Minneapolis Exposition and Conference
9. Health 2.0 and DrGreene.com to Host Inaugural Body 2.0 Expo
10. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
11. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Calif. , May 25, 2016  Zymo ... testing for their new reference materials that help ... from sample collection to analyses. The rapid growth ... demand for researchers to have standard methods to ... being generated. Biases inherently exist at every step ...
(Date:5/25/2016)... As illustrated by the Spring ... the numbers and momentum of cannabis in the US ... billions, more research and development push the sector forward. ... Legal Marijuana Markets Report  from from ArcView Market Research ... the increase in sector is attributed to adult use ...
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... ... Blood Pressure products . , High blood pressure affects millions of people ... high blood pressure can lead to heart disease, stroke, kidney disease, and hardening ...
(Date:5/26/2016)... , ... May 26, 2016 , ... HealthPostures, ergonomics designer ... chair , furniture that may support women during pregnancy. Potential benefits of using the ... improved rest and comfort and healthier levels of sitting and standing. , Need for ...
(Date:5/26/2016)... ... May 26, 2016 , ... Bunion Bootie is a great option ... and save. For a limited time only (offer expires May 31, 2016) customers can ... one, by using the promo code "Memorial" at checkout. The more Bunion Booties purchased, ...
(Date:5/25/2016)... (PRWEB) , ... May 26, 2016 , ... The 12th ... 6pm to 7.30pm PST at HP in Palo Alto, CA. This Bay Area biotech ... be led by clinical trial experts from the pharmaceutical company Hallux, biopharma Apexigen, Contract ...
(Date:5/25/2016)... Chicago, IL (PRWEB) , ... May 25, 2016 ... ... HealthScape Advisors,” said Steven Young, a Managing Partner at HealthScape Advisors. “Brad brings ... value-based care within the healthcare delivery system accelerates with the implementation of MACRA, ...
Breaking Medicine News(10 mins):